DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (Amex:AXK) announced today that that Becton Dickinson and Company (NYSE: BDX) purchased an exclusive right on December 12, 2007 to negotiate for a business relationship to develop Accelr8’s BACcel® rapid diagnostic platform. The right grants to BD an exclusive discussion period through March 31, 2008 during which the companies will explore a possible product development relationship and definitive terms for such a relationship. If an agreement is reached, terms may include any of the elements or combination of elements of licensing, equity investment, joint development, or other mutually suitable product development and commercialization program. BD will pay Accelr8 $100,000 for the right.
